Disease | pick disease |
Comorbidity | C0026848|myopathy |
Sentences | 27 |
PubMedID- 21249466 | Mutations in the vcp gene including r93, r155, and r191 have been described that manifest clinically as hereditary inclusion body myopathy with paget's disease of bone and frontotemporal dementia. |
PubMedID- 23868359 | Inclusion body myopathy with paget disease of the bone and frontotemporal dementia associated with a novel g156s mutation in the vcp gene. |
PubMedID- 25775548 | Dominant mutations in p97/vcp (valosin-containing protein) cause a rare multisystem degenerative disease with varied phenotypes that include inclusion body myopathy, paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. |
PubMedID- 21320982 | Background: missense mutations in the valosin-containing protein (vcp) gene on chromosome 9p13.3-p12 cause inclusion body myopathy with paget disease of bone and frontotemporal dementia (hereafter referred to as ibmpfd; omim 167320). |
PubMedID- 25724235 | Valosin containing protein (vcp)-associated multisystem proteinopathy is a new hereditary disorder associated with inclusion body myopathy, paget disease of bone (pdb), frontotemporal dementia (ftd) and als. |
PubMedID- 23782824 | Inclusion body myopathy with paget's disease of bone and frontotemporal dementia (ibmpfd) is caused by mutations in the valosin-containing protein (vcp) gene. |
PubMedID- 22105166 | Inclusion body myopathy with paget disease of the bone and frontotemporal dementia (ibmpfd) is a multisystem degenerative disorder caused by mutations in the valosin-containing protein (vcp) gene. |
PubMedID- 24829604 | Background: inclusion-body myopathy with paget's disease of the bone and frontotemporal dementia (ibmpfd) is a rare, late-onset autosomal disorder arising from missense mutations in a gene coding for valosin-containing protein. |
PubMedID- 24291843 | [inclusion body myopathy with paget's disease of bone and frontotemporal dementia]. |
PubMedID- 21304887 | Inclusion body myopathy with paget's disease of bone and frontotemporal dementia (ibmpfd) is caused by mutations in valosin-containing protein (vcp), a hexameric aaa atpase that participates in a variety of cellular processes such as protein degradation, organelle biogenesis, and cell-cycle regulation. |
PubMedID- 20301649 | Inclusion body myopathy with paget disease of bone and/or frontotemporal dementia |
PubMedID- 23782825 | Findings were compatible with inclusion body myopathy with paget's disease of bone and frontotemporal dementia. |
PubMedID- 24348398 | Psychiatric presentation of frontotemporal dementia associated with inclusion body myopathy due to the vcp mutation (r155h) in a french family. |
PubMedID- 21607982 | Axonal hyperpolarization in inclusion-body myopathy, paget disease of the bone, and frontotemporal dementia (ibmpfd). |
PubMedID- 22105171 | Inclusion body myopathy with paget disease of bone and frontotemporal dementia (ibmpfd) is an autosomal dominant disorder characterized by progressive myopathy that is often accompanied by bone weakening and/or frontotemporal dementia. |
PubMedID- 20335036 | Two australian families with inclusion-body myopathy, paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. |
PubMedID- 23715207 | Inclusion body myopathy with paget disease of bone and frontotemporal dementia is a progressive autosomal dominant disorder associated with a mutation in valosin-containing protein (vcp) with typical onset of symptoms in the 30s. |
PubMedID- 22557993 | Finally, type d refers to the pathology associated to inclusion body myopathy with paget’s disease of bone and frontotemporal dementia caused by chmp2b vcp gene mutations, and is characterized by numerous short dn and frequent lentiform nii. |
PubMedID- 25457024 | Accumulating evidence has proven that mutations in the vcp gene encoding valosin-containing protein (vcp) cause inclusion body myopathy with paget disease of the bone and frontotemporal dementia. |
PubMedID- 21920633 | Mutations in the valosin-containing protein gene (vcp) have been identified in neurological disorders (inclusion body myopathy--early paget's disease of the bone--frontotemporal dementia and amyotrophic lateral sclerosis) and are thought to play a role in the clearance of abnormally folded proteins. |
PubMedID- 22909335 | Valosin containing protein (vcp) disease associated with inclusion body myopathy, paget disease of the bone and frontotemporal dementia is a progressive autosomal dominant disorder caused by mutations in valosin containing protein gene. |
PubMedID- 24119107 | Valosin containing protein (vcp) disease (also known as inclusion body myopathy, paget disease of bone and frontotemporal dementia [ibmpfd] syndrome) is caused by mutations in the gene encoding vcp classically affecting the muscle, bone and brain. |
PubMedID- 22337587 | Of clinical importance, p97 mutants found in familial neurodegenerative conditions inclusion body myopathy paget's disease of the bone and/or frontotemporal dementia and amyotrophic lateral sclerosis are defective at interacting with ubxd1, indicating that functions regulated by a p97-ubxd1 complex are altered in these diseases. |
PubMedID- 22449146 | Both neurofibromatosis type i (nf1) and inclusion body myopathy with paget's disease of bone and frontotemporal dementia (ibmpfd) are autosomal dominant genetic disorders. |
PubMedID- 22040362 | Background and purpose: mutations in the valosin-containing protein (vcp) gene are known to cause inclusion body myopathy with paget's disease of bone and frontotemporal dementia (ibmpfd) and familial amyotrophic lateral sclerosis (als). |
PubMedID- 20490813 | Mutations in valosin-containing protein (vcp) cause inclusion body myopathy and paget disease of bone with frontotemporal dementia, in which 20–100% of patients can develop ftd [10, 53, 56]. |
PubMedID- 25582679 | Inclusion body myopathy, paget disease of bone and/or frontotemporal dementia is an autosomal dominant disease caused by mutations in the valosin containing protein (vcp) gene. |
Page: 1